These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 26385431)

  • 1. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.
    Haq SA; Tournadre A
    Int J Rheum Dis; 2015 Nov; 18(8):818-25. PubMed ID: 26385431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.
    de Padilla CM; Reed AM
    Curr Opin Rheumatol; 2008 Nov; 20(6):669-74. PubMed ID: 18946326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.
    Bhattarai S; Ghannam K; Krause S; Benveniste O; Marg A; de Bruin G; Xin BT; Overkleeft HS; Spuler S; Stenzel W; Feist E
    J Autoimmun; 2016 Dec; 75():118-129. PubMed ID: 27522114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy.
    Megens-de Letter MA; Visser LH; van Doorn PA; Savelkoul HF
    Eur Cytokine Netw; 1999 Dec; 10(4):471-8. PubMed ID: 10586113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
    De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
    Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel aspects on the contribution of T cells and dendritic cells in the pathogenesis of myositis.
    Chevrel G; Page G; Miossec P
    Autoimmunity; 2006 May; 39(3):171-6. PubMed ID: 16769650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies.
    Grundtman C; Malmström V; Lundberg IE
    Arthritis Res Ther; 2007; 9(2):208. PubMed ID: 17389031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-chemokine receptor expression in idiopathic inflammatory myopathies.
    De Paepe B; De Bleecker JL
    Muscle Nerve; 2005 May; 31(5):621-7. PubMed ID: 15772970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of dermatomyositis.
    Thompson C; Piguet V; Choy E
    Br J Dermatol; 2018 Dec; 179(6):1256-1262. PubMed ID: 28542733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syrian hamster infected with Leishmania infantum: a new experimental model for inflammatory myopathies.
    Paciello O; Wojcik S; Gradoni L; Oliva G; Trapani F; Iovane V; Politano L; Papparella S
    Muscle Nerve; 2010 Mar; 41(3):355-61. PubMed ID: 19813199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
    Ernste FC; Reed AM
    Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge issues in polymyositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Gorza L; Doria A
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):179-89. PubMed ID: 21191666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.
    Venalis P; Lundberg IE
    Rheumatology (Oxford); 2014 Mar; 53(3):397-405. PubMed ID: 23970542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications.
    Greenberg SA
    Neurology; 2007 Nov; 69(21):2008-19. PubMed ID: 17928577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th1 and Th17 balance in inflammatory myopathies: interaction with dendritic cells and possible link with response to high-dose immunoglobulins.
    Tournadre A; Porcherot M; Chérin P; Marie I; Hachulla E; Miossec P
    Cytokine; 2009 Jun; 46(3):297-301. PubMed ID: 19303320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies.
    Wiendl H; Mitsdoerffer M; Schneider D; Chen L; Lochmüller H; Melms A; Weller M
    FASEB J; 2003 Oct; 17(13):1892-4. PubMed ID: 12923066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinesin superfamily motor protein KIF4 is associated with immune cell activation in idiopathic inflammatory myopathies.
    Bernasconi P; Cappelletti C; Navone F; Nessi V; Baggi F; Vernos I; Romaggi S; Confalonieri P; Mora M; Morandi L; Mantegazza R
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):624-32. PubMed ID: 18520780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immature muscle precursors are a source of interferon-β in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation.
    Tournadre A; Lenief V; Eljaafari A; Miossec P
    Arthritis Rheum; 2012 Feb; 64(2):533-41. PubMed ID: 22094963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new biomarkers of idiopathic inflammatory myopathy.
    Lu X; Peng Q; Wang G
    Clin Chim Acta; 2015 Apr; 444():117-25. PubMed ID: 25681646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytokines and chemokines in idiopathic inflammatory myopathies.
    De Paepe B; Creus KK; De Bleecker JL
    Curr Opin Rheumatol; 2009 Nov; 21(6):610-6. PubMed ID: 19726994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.